456 related articles for article (PubMed ID: 10221658)
1. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
[TBL] [Abstract][Full Text] [Related]
2. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
4. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
[TBL] [Abstract][Full Text] [Related]
5. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
Zika E; Greer SF; Zhu XS; Ting JP
Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
[TBL] [Abstract][Full Text] [Related]
8. Regulation of class II expression in monocytic cells after HIV-1 infection.
Rakoff-Nahoum S; Chen H; Kraus T; George I; Oei E; Tyorkin M; Salik E; Beuria P; Sperber K
J Immunol; 2001 Aug; 167(4):2331-42. PubMed ID: 11490022
[TBL] [Abstract][Full Text] [Related]
9. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
[TBL] [Abstract][Full Text] [Related]
10. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
Mudhasani R; Fontes JD
Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
[TBL] [Abstract][Full Text] [Related]
11. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
12. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.
Holling TM; van der Stoep N; Quinten E; van den Elsen PJ
J Immunol; 2002 Jan; 168(2):763-70. PubMed ID: 11777970
[TBL] [Abstract][Full Text] [Related]
13. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
[TBL] [Abstract][Full Text] [Related]
15. Chromatin remodeling and extragenic transcription at the MHC class II locus control region.
Masternak K; Peyraud N; Krawczyk M; Barras E; Reith W
Nat Immunol; 2003 Feb; 4(2):132-7. PubMed ID: 12524537
[TBL] [Abstract][Full Text] [Related]
16. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.
Mudhasani R; Fontes JD
Mol Cell Biol; 2002 Jul; 22(14):5019-26. PubMed ID: 12077331
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong Y; Rohn WM; Benveniste EN
J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
[TBL] [Abstract][Full Text] [Related]
18. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
Taxman DJ; Cressman DE; Ting JP
J Immunol; 2000 Aug; 165(3):1410-6. PubMed ID: 10903745
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.
Deffrennes V; Vedrenne J; Stolzenberg MC; Piskurich J; Barbieri G; Ting JP; Charron D; Alcaïde-Loridan C
J Immunol; 2001 Jul; 167(1):98-106. PubMed ID: 11418637
[TBL] [Abstract][Full Text] [Related]
20. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
Lochamy J; Rogers EM; Boss JM
Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]